The Conference Forum Announces A New Medicaid Rebate Summit for Early 2013

A new Medicaid Rebate Summit in 2013 will address the interpretation of the anticipated Final Rule, the larger implications of health care reform including financial and operational impact as well as dispute resolution.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Medicaid Rebate Summit
With all of the pending changes around government pharmaceutical programs this conference brings together leading
industry and government experts all in one place to provide you with valuable insight into the future.

New York, New York (PRWEB) December 19, 2012

The Conference Forum, recognized in the pharmaceutical industry for its interactive-style meetings, announced a new conference to navigate the complexities of the Medicaid Rebate process. The Medicaid Rebate Summit brings manufacturers together with State Medicaid and Pharmacy leaders to work through the interpretation of the anticipated Final Rule, the larger implications of health care reform and its financial and operational impact as well as resolutions for disputes.

Alice Valder Curran of Hogan Lovells opens the program with remarks on interpreting the Final Rule – a “hot” topic for 2013. The 2013 Medicaid Rebate Summit fosters relationships between drug manufactures and state agencies in order to better serve the Medicaid population. Attendees will:

  • Hear pertinent Health Care Association insights on health care reform and POVs from Managed Markets, Government Contracting, Pricing and Reimbursement, States and Consultants.
  • Participate in a Q&A with CMS representation lead by LaDonna Steiner of Purdue Pharma.

The conference has two track choices to allow individual event customization. Track One, chaired by Heather Dixson, Director Government Price Reporting, Eli Lilly & Co will address interpretation and implementation of the Final Rule. Track Two, chaired by Ed McAdam, Senior Director, Pricing & Analytics, Daiichi Sankyo, Inc. will focus on 340B, Government Pricing and Reimbursement.

When speaking about his involvement McAdams said, “With all of the pending changes around government pharmaceutical programs this conference brings together leading industry and government experts all in one place to provide you with valuable insight into the future.”

Event Details:

Medicaid Rebate Summit
Date: February 14-15, 2013
Location: Park Hyatt Washington, Washington, DC
Click here to register.

Pre-Conference Medicaid Rebate Bootcamp
The workshop is designed for professionals either new to the Medicaid Rebate space or
for those looking for a refresher course on the basics.
Date: February 13, 2013
Location: Park Hyatt Washington, Washington, DC
Click here to register.

For program details click here
Questions, please email service(at)theconferenceforum(dot)org

Speakers Include:

  • Derek Asay, Eli Lilly & Co.
  • George Bilyk, Janssen
  • JoAnn Bute, Amneal Pharmaceuticals
  • Kevin Cast, Express Scripts
  • Chris Cobourn, CIS
  • Cori Cooper, PharmD, Wyoming Department of Health
  • Thomas Corcoran, Assistant US Attorney, District of Maryland
  • John Coster, PhD, RPh, National Community Pharmacists Association
  • Alice Valder Curran, Hogan Lovells
  • Tarra DeShields, Assistant U.S. Attorney, Civil Division, District of Maryland
  • Heather Dixson Eli Lilly & Co.
  • Audrey Fletcher, CIS
  • Sharon Greeson, RPh, HP
  • Edmund Haislmaier, Heritage Foundation
  • Christopher A. Hatwig, MS, RPh, FASHP, APEXUS/ 340B Prime Vendor
Program
  • Mike Hepburn, Janssen R&D, LLC
  • Rich Holsapple, RPh, Oregon MMIS, HP Enterprise Services
  • Christopher Jackson, Bayer HealthCare LLC
  • Ann Kaplan, PhRMA
  • Julie Khani, National Association of Chain Drug Stores
  • Mitch Lazris, Hogan Lovells
  • Lori Martin, Eli Lilly & Co.
  • Paula Martins, Daiichi Sankyo, Inc.
  • Jesse Mensah, Celgene
  • Ed McAdam, Daiichi Sankyo, Inc.
  • Lisa McNair, Reckitt Benckiser
  • Jennifer Norton, Vertex Pharmaceuticals, Inc.
  • Brian Osberg, National Governors Association
  • Viveca Parker, Assistant US Attorney, Civil Division United States,
Eastern District of PA
  • DR Krista Pedley, HRSA Office of Pharmacy Affairs
  • Erica Petersohn, CIS
  • Bill Phillips, CIS
  • Joann S. Prushinski, Genentech, Inc.
  • Kent Rogers, MBA, Acorda Therapeutics
  • Matt Sheffield, Boehringer Ingelheim Pharmaceuticals, Inc.
  • LaDonna Steiner, Purdue Pharma
  • Laurel Todd, MBA, BIO

About The Conference Forum:
The Conference Forum has a very specific focus – developing specialized events both public and private as well as research groups and advisory boards for professionals in the life science industry. We currently offer conferences for R&D leaders, Clinical Development professionals, young and established Biotech executives, and Drug Delivery specialists. Our mission is to create the best content in an ideal forum for the exchange of ideas among peers and networking for Pharmaceutical and Biotech professionals.


Contact

Follow us on: Contact's Twitter

Attachments